BC |
Breast Cancer |
TILs |
tumor infiltrating lymphocytes |
DCs |
dendritic cells |
Tregs |
CD4+ regulatory T cells |
CIC |
cancer-immunity cycle |
TIME |
tumor immune microenvironment |
CYT |
immune cytolytic activity |
TCGA |
The Cancer Genome Atlas |
METABRIC |
Molecular Taxonomy of Breast Cancer International Consortium |
TN |
triple negative |
ER |
estrogen receptor |
PgR |
progesterone receptor |
HR |
hormone receptor |
TMB |
tumor mutation burden |
SNV |
single-nucleotide variant |
IFN |
interferon |
GSEA |
Gene Set Enrichment Analyses |
NES |
normalized enrichment score |
FDR |
false discovery rate |
OS |
overall survival |
HER2 |
human epidermal growth factor receptor 2 |
PFS |
progression free survival |
BCSS |
breast cancer specific survival |
NCI |
National Cancer Institute |
TPM |
Transcripts Per Million |
RFS |
recurrence-free survival |